Fund HoldingsParadigm Biocapital Advisors LP

Total Portfolio Value
$5.34B
Total Bought
$1.59B
Total Sold
$2.26B
Net Transaction
-$671.78M
Filing Period:
Securities
SharesValue ($K)
Q1 2026
Q2 2026
Change
Q1 2026
Q2 2026
Weight (%)
Change
REVOLUTION MEDICINES INC(RVMD)6,655,7036,361,323-294,380647,2671,191,34922.31%+544,081
SPYRE THERAPEUTICS INC(SYRE)1,957,2663,840,778+1,883,51298,724340,9846.38%+242,260
NUVALENT INC5,324,4335,924,433+600,000545,488731,66713.70%+186,179
EDGEWISE THERAPEUTICS INC(EWTX)7,365,03810,215,455+2,850,417231,999415,0547.77%+183,055
GENMAB A/S(GMAB)7,967,83613,133,131+5,165,295213,777360,7676.76%+146,990
ALNYLAM PHARMACEUTICALS INC(ALNY)0480,000+480,0000144,4942.71%+144,494
MBX BIOSCIENCES INC(MBX)02,508,015+2,508,0150138,4422.59%+138,442
TANGO THERAPEUTICS INC(TNGX)4,009,6796,357,523+2,347,84483,882198,7363.72%+114,854
APOGEE THERAPEUTICS INC(APGE)1,348,2431,576,385+228,142113,482209,2343.92%+95,752
ORUKA THERAPEUTICS INC(ORKA)2,320,3162,144,526-175,790113,812204,0953.82%+90,283
JADE BIOSCIENCES INC02,857,405+2,857,405063,4921.19%+63,492
VIRIDIAN THERAPEUTICS INC(VRDN)3,148,8936,723,788+3,574,89561,592123,5162.31%+61,924
ACHIEVE LIFE SCIENCE INC04,951,856+4,951,856032,3360.61%+32,336
MAPLIGHT THERAPEUTICS INC(MPLT)0685,852+685,852024,5810.46%+24,581
ASSEMBLY BIOSCIENCES INC665,2511,553,748+888,49718,46142,6970.80%+24,236
KARDIGAN INC0900,000+900,000021,4650.40%+21,465
EDITAS MEDICINE INC(EDIT)05,586,625+5,586,625018,1010.34%+18,101
BELITE BIO INC(BLTE)1,114,7841,232,877+118,093177,741189,8453.55%+12,103
ERASCA INC(ERAS)10,392,7029,550,000-842,702168,154174,9563.28%+6,802
VOR BIOPHARMA INC(VOR)1,750,0001,750,000031,22032,2180.60%+998
EYEPOINT INC(EYPT)3,142,4372,890,397-252,04040,50641,3330.77%+827
KALARIS THERAPEUTICS INC(KLRS)700,0000-700,0004,0390-4,039
TARSUS PHARMACEUTICALS INC(TARS)2,562,1542,775,649+213,495179,735174,6993.27%-5,036
INVENTIVA SA(IVA)4,000,0004,000,000022,20015,1200.28%-7,080
BRIDGEBIO ONCOLOGY THERAPEUT(BBOT)868,2130-868,2137,7710-7,771
OLEMA PHARMACEUTICALS INC(OLMA)8,020,5768,670,576+650,000119,587108,4692.03%-11,118
LEXEO THERAPEUTICS INC(LXEO)6,184,1344,175,382-2,008,75235,49719,4360.36%-16,061
TYRA BIOSCIENCES INC(TYRA)2,054,9911,828,607-226,38478,70658,4061.09%-20,300
ORIC PHARMACEUTICALS INC(ORIC)1,701,2170-1,701,21721,5540-21,554
STRUCTURE THERAPEUTICS INC545,2870-545,28726,2830-26,283
UROGEN PHARMA LTD(URGN)1,703,9490-1,703,94930,6370-30,637
VERADERMICS INC(MANE)525,0000-525,00033,1540-33,154
MIRUM PHARMACEUTICALS INC(MIRM)625,0000-625,00057,7380-57,737
SCHOLAR ROCK HLDG CORP(SRRK)1,226,0800-1,226,08060,2740-60,274
INSMED INC(INSM)1,254,4881,325,977+71,489205,134141,3762.65%-63,758
MAZE THERAPEUTICS INC(MAZE)2,744,3990-2,744,39981,9200-81,920
ABIVAX SA(ABVX)772,4730-772,47386,0150-86,015
CYTOKINETICS INC(CYTK)1,480,8570-1,480,85797,6030-97,603
TERNS PHARMACEUTICALS INC2,216,4990-2,216,499116,8540-116,854
CENTESSA PHARMACEUTICALS PLC3,574,0480-3,574,048141,9610-141,961
VAXCYTE INC(PCVX)4,793,0202,127,852-2,665,168278,522123,6922.32%-154,830
ARCELLX INC
COMMON STOCK
5,774,0160-5,774,016662,9730-662,973
Page 1 of 1
Paradigm Biocapital Advisors LP — 13F Holdings — Q2 2026 | TickerTrail